A polydrug addict is someone who regularly uses two or more substances, either at the same time or within a short period. This pattern is far more common than single-substance addiction. In overdose deaths tracked by medical examiners in Los Angeles County, the average number of drugs found per death rose from 1.72 in 2012 to 2.29 in 2023, and by 2023, 74% of multi-drug deaths involved three or more substances.
The term “polydrug” simply means “multiple drugs.” Someone who drinks alcohol and uses cocaine on the same night, or who takes opioids and anti-anxiety medications throughout the week, fits the description. The substances don’t have to be illegal. Alcohol, prescription medications, and illicit drugs all count.
Why People Use Multiple Substances
People who use several drugs rarely do so randomly. Research into the motivations behind polysubstance use identifies a few consistent patterns. The most common is balancing: using one substance to counteract the unwanted effects of another. A person might use a stimulant to stay alert after taking a sedative, or drink alcohol to ease the jittery comedown from cocaine. Another motivation is enhancement, combining substances to intensify a high beyond what either produces alone. Some people also substitute, using a more available or cheaper drug to mimic the effect of their preferred substance when they can’t get it.
These motivations matter because they reveal how deeply interlocked the substances become in a person’s routine. It’s not simply two separate habits running in parallel. The drugs form a system, where each one plays a role that makes the others feel necessary.
How Different Drug Combinations Affect the Body
When two substances enter the body together, their combined effect isn’t always predictable. Sometimes the result is roughly the sum of the two individual effects. Other times, the drugs interact through shared pathways in the brain or liver, producing an effect far greater than either would alone. This amplification, called synergy, is what makes certain combinations especially dangerous.
Alcohol and Cocaine
When cocaine and alcohol are consumed together, the liver produces a third compound called cocaethylene. This metabolite acts like cocaine but lasts longer in the bloodstream (roughly two hours versus one hour for cocaine alone) and is estimated to be over 10 times more toxic to the heart. Cocaethylene raises heart rate and blood pressure more than cocaine by itself and slows the electrical signals that coordinate heartbeats. In a study of six healthy volunteers who took both substances, all had heart rates significantly elevated beyond what either drug produced on its own. People who combine the two often report a longer, more intense high, which is exactly the effect of cocaethylene blocking the brain’s dopamine recycling system for an extended period.
Opioids and Anti-Anxiety Medications
The combination of opioids and benzodiazepines (drugs like Xanax, Valium, or Klonopin) is one of the deadliest pairings in substance use. Both drug classes suppress the brain’s breathing centers, but through different receptor systems. Opioids act on opioid receptors in the brainstem while benzodiazepines act on GABA receptors concentrated in the same area. Together, they can suppress breathing to the point of death. Benzodiazepines have been identified in 50 to 80% of heroin-related deaths and up to 80% of deaths involving buprenorphine, a medication used to treat opioid addiction. Benzodiazepines actually eliminate buprenorphine’s built-in safety ceiling on respiratory depression, removing the very feature that makes it safer than other opioids.
Fentanyl and Xylazine
A newer combination gaining attention is fentanyl mixed with xylazine, a veterinary sedative known on the street as “tranq.” The White House declared this combination an emerging threat in April 2023. Xylazine is not an opioid, which means naloxone (Narcan) does not reverse its sedating effects. People using this combination face the overdose risk of fentanyl plus prolonged unconsciousness from xylazine, during which breathing can remain dangerously slow even after naloxone is administered. Xylazine also causes severe skin ulcerations that can develop at sites far from where the drug was injected, and even in people who don’t inject at all. These wounds require specialized care that most addiction treatment facilities aren’t equipped to provide, creating a barrier to getting help.
How Polydrug Addiction Is Diagnosed
The clinical language around this has shifted over the years. The previous edition of the main psychiatric diagnostic manual included a category called “polysubstance dependence,” which allowed a diagnosis when someone met criteria for addiction across multiple substances collectively, even if no single substance qualified on its own. That category was widely misunderstood and rarely used, so it was eliminated in 2013.
Today, each substance is diagnosed separately. A person might receive a diagnosis of alcohol use disorder and opioid use disorder at the same time. The current system classifies severity by counting how many of 11 possible criteria a person meets: two to three criteria is mild, four to five is moderate, and six or more is severe. Criteria include things like craving, using more than intended, continuing use despite harm, and withdrawal symptoms. The threshold for any diagnosis is just two criteria.
In practice, this means someone using four substances could carry four separate diagnoses. That’s not a technicality. It directly affects what treatments are recommended and how insurance covers care.
Why Treatment Is More Complicated
Treating polydrug addiction is harder than treating single-substance addiction for several overlapping reasons. Withdrawal timelines differ between substances, so a person may be in acute withdrawal from one drug while still managing the tail end of another. The brain’s reward system has been altered by multiple chemicals acting on different pathways, making recovery less straightforward than simply removing one substance.
Medications that work for one substance may interact unpredictably with another. National guidelines are clear that using multiple substances is not a reason to withhold treatment. Someone using both opioids and stimulants, for example, should still receive medication for opioid use disorder, though they may need more intensive monitoring and support.
Evidence-based approaches like contingency management (which provides tangible rewards for staying drug-free) and cognitive behavioral therapy show promise for people with multiple substance use disorders. However, these approaches face significant barriers when it comes to implementation in real-world clinical settings, meaning many treatment programs don’t offer them consistently. The result is that polydrug users often receive a treatment plan designed around their most acute substance problem while their other substance use receives less attention.
Reducing Harm When Using Multiple Substances
Research on people who use multiple substances has identified several strategies that are associated with fewer harms. These include setting a firm limit on the total quantity of each substance before using, taking smaller doses of each drug than you would take if using it alone, waiting for one substance’s effects to fade before taking another, and being especially cautious about combining drugs in the same category. Mixing two depressants (like alcohol and opioids) or two stimulants (like cocaine and methamphetamine) carries higher risk than combining drugs from different classes, because same-category drugs amplify each other’s most dangerous effects.
Fentanyl test strips, which detect the presence of fentanyl in other drug supplies, have become a critical tool as fentanyl increasingly contaminates stimulants, counterfeit pills, and other substances that users don’t expect to contain opioids. Many polysubstance overdose deaths now involve fentanyl that the person didn’t know they were taking.